Benzonatate Capsule
Product Images NDC 42708-082

2 FDA label images from Qpharma, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 42708-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

42708-082-21 Benzonatate Capsules Usp 200mg X 21 (Benzonatate Act 200mg 100cc)

42708-082-21 Benzonatate Capsules Usp 200mg X 21 (Benzonatate Act 200mg 100cc)
Label for Benzonatate Capsules USP, 200 mg, containing 21 capsules. The label states the product is a sample not for sale with directions to see the package insert for dosage. Distributed by QPharma, Inc., Cedar Knolls, NJ. Instructions for use are partially blank for customization. The label includes storage instructions to store at controlled room temperature and warnings to keep the container tightly closed and out of reach of children. Marked Rx Only.*
FDA Label Image

Chemical Structure (Structure)

Chemical Structure (Structure)
Chemical structure of Benzonatate showing its molecular arrangement with the formula C30H53NO11. The diagram includes a benzene ring, ether groups, and various alkyl chains as part of the molecular structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.